Displaying 1541 - 1560 of 2087
FTC Staff: Massachusetts Should Consider Removing Physician Supervision Requirements for Nurse Practitioners and Nurse Anesthetists
FTC Requires Community Health Systems, Inc. to Divest Two Hospitals as a Condition of Acquiring Rival Hospital Operator
FTC Announces Revised Thresholds for Clayton Act Antitrust Reviews for 2014
FTC Seeks Public Comment on Toys “R” Us Petition to Reopen and Modify Final Commission Order
FTC Seeks Public Comment on Franchise Services of North America’s Application for Approval to Sell Advantage Rent a Car to The Catalyst Capital Group, Inc.
FTC Approves Pinnacle Entertainment, Inc.’s Application to Divest One of Its Casinos in St. Louis, Missouri, to Tropicana St. Louis LLC
FTC Seeks Public Comment on Tesoro Corporation’s Application to Divest Boise, Idaho, Terminal Business and Related Assets to Sinclair Transportation Co.
FTC to Hold Rescheduled Workshop on February 4 Examining the Competitive Impacts of State Regulations and Naming Conventions Concerning Follow-on Biologics
FTC Puts Conditions on Fidelity National Financial’s Acquisition of Lender Processing Services
FTC Requires Albertson’s Supermarkets to Sell Two Texas Stores as a Condition of Acquiring Regional Grocery Chain United
FTC Puts Conditions on Service Corporation International’s Proposed $1.4 Billion Acquisition of Rival Funeral and Cemetery Services Provider
FTC Approves Final Order Settling Charges that Pinnacle Entertainment, Inc.’s Acquisition of Rival Firm Ameristar Casinos, Inc. Would be Anticompetitive in Two Markets
FTC Approves Final Order Settling Charges That Mylan, Inc.’s Acquisition of Agila Specialties Global Pte. Ltd and Agila Specialties Pvt. Ltd. Was Anticompetitive
FTC Approves Polypore International’s Application to Sell Microporous to Seven Mile Capital Partners; Sale Will Unwind Illegal 2008 Acquisition
Polypore International, Inc., In the Matter of
In the matter of Polypore International/Daramic LLC, the Commission issued an administrative complaint challenging Polypore’s consummated acquisition of Microporous Products in the global market for battery separators, a key component in flooded lead-acid batteries. According to the Commission’s complaint, the acquisition, which occurred in February 2008, substantially lessened competition and led to higher prices in several North American product markets including 1) deep-cycle separators used in golf carts, 2) motive separators for batteries used primarily in forklifts, 3) automotive separators used in car batteries, and 4) uninterruptible power supply (UPS) separators used in batteries that provide backup power during power outages. Additionally, the complaint alleged that Polypore engaged in anticompetitive conduct by entering into a joint marketing agreement with a competitor, restricting the competitor’s entry into the polyethylene battery separator markets. The complaint also charged that Polypore sought to maintain monopoly power through anticompetitive means in several battery separator markets. On 3/8/2010, the ALJ announced an Initial Decision finding that Polypore International Inc.’s consummated acquisition – through its Daramic Acquisition Corporation subsidiary – of rival battery separator manufacturer Microporous L.P. was anticompetitive and violated federal law in four battery separator markets in North America. In an Order filed with the Initial Decision on 2/22/2010, Judge Chappell ordered Polypore to divest Microporous to an FTC-approved buyer within six months after the divestiture provisions of the Order become final. Judge Chappell also ruled that a 2001 joint marketing agreement between Polypore and a rival battery separator manufacturer illegally divided up the markets for particular types of battery separators in North America, and ordered Polypore to amend the agreement to terminate and declare null and void the covenant not to compete. Finally, the Judge dismissed a separate allegation that Polypore engaged in exclusionary conduct in specific battery separator markets. In December of 2010, the Commission voted to uphold in large part the March 2010 Initial Decision, finding that the acquisition reduced competition in three of the four relevant markets, and ordering divestiture. Polypore subsequently filed a petition for review of the Commission's Decision and Order in the US court of Appeals for the Eleventh Circuit. On 07/12/2012, the U.S. Court of Appeals upheld the FTC's Opinion and Order, and on 06/24/2013, the Supreme Court denied Polypore's petition for certioari. In December 2013, the FTC approved the sale of all stock and assets related to Microporous to Seven Mile Capital Partners.
Professional Associations Settle FTC Charges by Eliminating Rules That Restricted Competition Among Their Members
FTC Approves Final Order Settling Charges that Actavis, Inc.’s Acquisition of Warner Chilcott plc Would Be Anticompetitive in Four Current and Future Drug Markets
FTC Postpones Follow-On Biologics Workshop Due to Inclement Weather
FTC Announces Agenda for Workshop Examining Competition Issues Surrounding Biologic and Follow-on Biologic Medicines: Biosimilars and Interchangeables
Displaying 1541 - 1560 of 2087